Rewalk Robotics Stock Fundamentals
| RWLKDelisted Stock | USD 0.74 0.01 1.33% |
Rewalk Robotics fundamentals help investors to digest information that contributes to Rewalk Robotics' financial success or failures. It also enables traders to predict the movement of Rewalk Stock. The fundamental analysis module provides a way to measure Rewalk Robotics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Rewalk Robotics stock.
Rewalk |
Rewalk Robotics Company Return On Equity Analysis
Rewalk Robotics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Rewalk Robotics Return On Equity | -0.34 |
Most of Rewalk Robotics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rewalk Robotics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Rewalk Robotics has a Return On Equity of -0.3424. This is 98.57% lower than that of the Health Care Equipment & Supplies sector and 96.08% lower than that of the Health Care industry. The return on equity for all United States stocks is 10.45% higher than that of the company.
Rewalk Robotics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Rewalk Robotics's current stock value. Our valuation model uses many indicators to compare Rewalk Robotics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Rewalk Robotics competition to find correlations between indicators driving Rewalk Robotics's intrinsic value. More Info.Rewalk Robotics is rated second in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Rewalk Robotics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Rewalk Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rewalk Robotics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rewalk Robotics could also be used in its relative valuation, which is a method of valuing Rewalk Robotics by comparing valuation metrics of similar companies.Rewalk Robotics is currently under evaluation in return on equity category among its peers.
Rewalk Fundamentals
| Return On Equity | -0.34 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.38) % | |||
| Operating Margin | (1.24) % | |||
| Current Valuation | 28.94 M | |||
| Shares Outstanding | 60.02 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 20.71 % | |||
| Number Of Shares Shorted | 1.36 M | |||
| Price To Earning | (0.77) X | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 6.89 X | |||
| Revenue | 9.15 M | |||
| Gross Profit | 1.91 M | |||
| EBITDA | (19.04 M) | |||
| Net Income | (21.81 M) | |||
| Cash And Equivalents | 78.83 M | |||
| Cash Per Share | 1.25 X | |||
| Total Debt | 897 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 22.05 X | |||
| Book Value Per Share | 0.86 X | |||
| Cash Flow From Operations | (20.1 M) | |||
| Short Ratio | 2.82 X | |||
| Earnings Per Share | (0.36) X | |||
| Target Price | 3.0 | |||
| Number Of Employees | 56 | |||
| Beta | 2.31 | |||
| Market Capitalization | 63.03 M | |||
| Total Asset | 74.24 M | |||
| Retained Earnings | (213.75 M) | |||
| Working Capital | 67.73 M | |||
| Current Asset | 23.78 M | |||
| Current Liabilities | 4.34 M | |||
| Z Score | 38.5 | |||
| Net Asset | 74.24 M |
About Rewalk Robotics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rewalk Robotics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rewalk Robotics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rewalk Robotics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel. Rewalk Robotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 51 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Rewalk Stock
If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |